ERYTECH PHARMA - Export company showcase @ B2B French Export Directory

ERYtech Pharma (Lyon, Philadelphia) is a specialty pharma developing new high value medicinal products for unmet clinical needs in the field of oncology, hematology and metabolic diseases.

ERYtech Pharma’s business model consists both of developing and selling new innovative medicinal products and of partnering with pharma/biotech companies.

ERYtech Pharma’s patented technology and platform offer large possibilities to create new products and IPs on an industrial scale.

ERYtech Pharma has built in less than five years a strong pipeline with very ambitious programs. Its lead program Graspa which started Phase III in Europe targets big oncology franchise in hematological malignancies and solid tumors.

In addition to its own products ERYtech developed powerful platform enabling:

(1) to develop new products with long circulating action with no release of the compounds

(2) to rapidly target specific dendritic cells and macrophages and have specific immune modulation applications.

ERYtech looks forward making innovative proof of concept with biotech/big pharma molecules and co-development partnering.

Legal Name	ERYTECH PHARMA
Director Name	GODFRIN Yann
French Legal Category	Limited liability company with board of directors
Registered capital (in Euros)	190 166
Year company founded	11/22/2004
Etablishment legal status	Limited liability company with board of directors
% Turnover from export	unknown
Related activities	Health, pharmacy, life sciences Biotechnology

> French-Business-Home > Company : ERYTECH PHARMA